• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Curtis Triplitt, PharmD, on Patient-Centered Diabetes Care

Article

In this interview, Curtis Triplitt, PharmD, associate professor and assistant dean of research, Texas Tech University Health Sciences Center, Permian Basin, explains why diabetes should be treated with a patient-centered approach.

In this interview, Curtis Triplitt, PharmD, associate professor and assistant dean of research, Texas Tech University Health Sciences Center, Permian Basin, explains why diabetes should be treated with a patient-centered approach. This means that therapies should be based on an individual, not a population. Patient-centered approaches require payer and provider to examine a patient’s specific characteristics and needs such as race, gender, comorbidities, and motivation. “You take those different characteristics of a patient, apply them to a particular drug, and see if they fit,” said Dr Triplitt. He compared prescribing a DPP-4 inhibitor, a well- tolerated once-a day-oral medication that fits well in a large population, with pramlintide, used in combination with insulin and in a smaller population.

Related Videos
Dr Mark Fendrick
Dr Vishnukamal Golla
Experts at the PCOC conference
Dr Sophia Humphreys
Dr Vivek Subbiah
Vivek Bhalla, MD, Stanford University School of Medicine
Dr Scott Soefje
Dr Brian Mulherin
Lucilla Piccari, MD, PhD, Hospital del Mar
Dries Cops, MSc, Hasselt University
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.